Core Tip: third quarter of 2010, China's medicine and health products to maintain the sound development of foreign trade,digital thermometer import and export amount of $ 15,686,000,000, an increase of 23.09%, export value of $ 10,213,000,000.
An increase of 21.83%, import value of $ 5,472,000,000, clinical thermometer an increase of 25.51%, import and export growth from the second quarter of the current rapid growth to moderate growth, one major factor is the health insurance last year from the financial crisis, the import and export been restored, raised the base year; the other hand, ear thermometer European and American market is my main export medical products market, slow economic recovery in the region, competitive currency devaluation will directly affect my total exports of medicine and health products.
The third quarter of 2010, China's medicine and health products import and export trade has maintained a good development, digital blood pressure monitor import and export volume $ 15,686,000,000, an increase of 23.09%, export value of $ 10,213,000,000, an increase of 21.83%, imports $ 5,472,000,000, an increase of 25.51% , import and export growth from the second quarter of the current rapid growth to moderate growth, one major factor is the import and export of medical insurance last year the impact of the financial crisis has been restored, raised the base year; the other hand, European and American market is my main export medical products market, slow economic recovery in the region, competitive currency devaluation will directly affect my total exports of medicine and health products. I have the European Union, the North American market for 5 months pharmaceutical exports at record high in September also hit a record high, the pressure appeared to inventory, while the export base of emerging markets is still limited, short-term high growth is still not on the export of China's overall medical obvious pull, market uncertainty highlights the expected slowdown in export growth in the fourth quarter will continue to medicine.
One. The international market differentiation, sustained high growth emerging pharmaceutical market, slowing European demand.
According to GTI statistics, enter the second half of the years, the global pharmaceutical market is a clear division, the EU market is subject to the debt crisis in some countries, the overall pharmaceutical market trend of stagflation presents, from the data analysis have been published in July, imports from the European Medicines rapid decline in six months, 9.07% to 2.91% in July month, of which Germany, France, the Netherlands, Italy, Switzerland and other major markets experienced negative growth in the month, at present, the debt crisis in Europe that EU countries have to tighten fiscal policy, which greatly restricted EU consumption and investment growth, short-term pharmaceutical market to further expand the limited space.
Meanwhile, the U.S. market is showing strong growth potential, as of August, the U.S. pharmaceutical imports increased by 19.83%, of which 8 single month increased by 39.26% year on year. The U.S. remains the world's largest pharmaceutical consumer market, according to IMS predicted that the next five years will reach an annual compound growth rate of 3% to 6%, due to the global pharmaceutical industry, the focus of production to developing countries, the U.S. pharmaceutical market will expand imports have strong leading role.
Emerging pharmaceutical markets continue to maintain high growth, Russia, Brazil, the most significant market growth, an increase of 48.05%, respectively, and 45.90%, Australia, Korea, South Africa and other markets increased by 20.75%, 27.64% and 28.85%.
January to July 2010 change in the global pharmaceutical market.
II. The pharmaceutical industry operating environment is good, steady growth in the domestic market.
According to industry data CEInet the third quarter, China's output of 526,500 tons of chemical raw materials, an increase of 14.38%, medicine production 508,800 tons, an increase of 19.07%, while cost factors and demand factors in common under the influence of domestic pharmaceutical manufacturing industry price index of industrial products, the third quarter was 103.4, an increase of 3.4% overall yield from the pharmaceutical growth, the domestic market, the level of increase in income, health care reform and many other positive stimulation, to maintain steady rapid growth, slow growth in the international market demand, and the comparative advantages of China's pharmaceutical production costs and improve the quality of drugs, will increase the import of pharmaceutical products, pharmaceutical production and domestic and international market demands are constantly expanding. However, from the data to see, as part of the bulk API products production capacity expansion, overcapacity some impact on profitability, therefore, the corresponding rate slowed industry investment, industry investment has declined.
III. Western commodities stable export growth, but price growth is weak.
The third quarter, Western commodity exports $ 5,964,000,000, an increase of 22.88%, of which Western pharmaceutical raw materials continue to be the driving classes major force in export growth, export value of $ 5,018,000,000, an increase of 19.57% of the total export of medicine products share of 85.53%, sustained growth depends on expansion of demand in major markets around the world, the European Union, India, the U.S. market year on year growth rate of 21.89%, respectively, 29.12%, 17.23%, of which India continues to be the largest exporter of bulk drugs.
Western medicine continues to maintain a high export growth, export value of the third quarter, 387 million, an increase of 28.99%, mainly in Asia and Africa for the export market, the proportion was 48.57% and 17.77%, the growth rate reached 20.48% and 17.77%, on European Union, the North American market is growing fast, the growth rate reached 47.60% and 28.09%. From the constitution of export enterprises, state-owned enterprises and private enterprises export market structure changed slightly, to Asia, Africa market share of exports declined, exports to Europe and the U.S. market share has significantly increased the growth in the third quarter, year on year export growth rate reached 147.28%, respectively, and 83.12%, the fastest-growing varieties of anti-infective drugs and vitamins drugs.
Consolidated third quarter, Western medicine raw material medicine and the market structure and growth rate analysis, the current commodity export growth in Western medicine relies mainly on the needs of the international market caused increase in the number of export driven, cost, resources prominent, while the focus of the global pharmaceutical industry the trend of shifting to Asia's export performance of foreign-funded enterprises in addition to growth, in part, transferred to domestic enterprises. On the other hand, the overall price is always at a low level of development of the industry's structural problems have become increasingly prominent, serious business homogeneous competition, changes in the international market impact of large, independent innovation and high value-added products are still scarce, sustainable development still exists the problem of inadequate stamina.
IV. Raising the cost of upgrades and medical equipment products to promote exports continue to grow.
Three quarters of medical equipment products continued to maintain rapid growth, export value of $ 3,785,000,000, an increase of 21.78%, of which, medical dressings, disposable supplies, health, rehabilitation supplies and other goods due to the impact of rising raw material prices, export prices are improved to varying degrees, of which, cotton wool, gauze, bandages prices rose 16.70%, unbleached cotton prices rose 16.40% of medical gauze, cotton towels, surgical towels, and other prices rose 4.81%.
According to 108th Canton Fair understanding of the situation, affected by the economic recovery, health, rehabilitation supplies being sought to massage equipment supplies for the rehabilitation of health care transactions on behalf of relatively strong, reflecting the view from the exhibitors and visiting buyers showed the number of geometric increase, significant increase in the number of European and American buyers, and interest in the larger medium-sized massage products, especially focus on new product functionality and intelligent design. Product categories from the trading point of view, after years of imitation of local enterprises to the current emphasis on independent research and development, have launched in this year's trade self-developed new products, and the first time to apply for patent protection, this phenomenon shows that our massage equipment industry to mature stage.
Diagnosis and treatment of hospital equipment into the healthy growth path this year, three quarters of exports of $ 1,211,000,000, an increase of 25.69%, of which foreign-funded enterprises are still dominant, accounting for 73.12% the proportion of exports, an increase of 24.24%. The share of state-owned and private enterprises is still low, but the development of faster, which exports three quarters of state-owned enterprises increased by 36.15%, the market expansion mainly for European and U.S. markets, an increase of 74.45%, respectively, and 66.97%, is cost-effective The main advantage of their exports, some products have begun to move to high-end market, combined with GTI data analysis, diagnosis and treatment of small and medium sized equipment in Europe and America less than 5% market share, market development potential.
Five. Medicine and rapid growth of imports, the market potential is still huge.
The third quarter, China's imports still continued the trend of sustained growth this year, increased by 25.51% year on year, the main source of imports for the United States, Germany, Japan, Switzerland, France and other developed countries, where treatment equipment, West medicine, pharmaceutical raw materials is the main imported varieties, the proportion accounted for 29.89%, respectively, 26.83% and 25.41%, respectively, year on year increase of 34.27%, 25.82% and 10.41%. Statistics from the global pharmaceutical market, China's import market share in the share of global market share is small, but the growth rate close to or more than three consecutive years of 20%, one of the fastest growing countries, from the continued expansion of China's pharmaceutical market Long-term trends, pharmaceutical imports will likely remain high long-term growth. (SOURCE: Medicare China Chamber of Commerce)